Christina S Williams, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1538 Schnell Dr, Arabi, LA 70032 Phone: 504-298-8177 Fax: 504-688-7226 |
News Archive
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
An estimated 7,000 patients, ages 11 and younger, are treated in hospital emergency departments (ED) each year largely from unsupervised ingestions of cough and cold medications.
When someone develops adult-acquired flatfoot deformity (AAFD), they are offered either a reconstruction or foot fusion depending on the severity of the flatfoot and their age. Typically reconstructions are performed in younger patients, while older patients undergo fusions, even though it can limit mobility.
Previous studies have shown an increased cancer risk within the dialysis and kidney transplant populations compared to the general population. However, it is unclear whether cancer increases the risk of kidney failure.
› Verified 4 days ago